Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

AZ, Pfizer, Lilly Novel Anticancers Head For India Debut

24 Apr 2019

• By Anju Ghangurde

Ribbons — NOVEL ANTICANCERS APPROVED IN INDIA • Source: Shutterstock

Related Content

Will 'Financial Toxicity’ Weigh Down 1L NSCLC Win For Tagrisso In India?

27 Aug 2018

Lilly Scores New Treatment Option For Verzenios In England

04 Apr 2019

Dual Approval For Verzenio Under International Review Scheme

18 Apr 2019

India's New Trial Rules Tick Right Boxes, Shed Interim Compensation Clause

01 Apr 2019

India New Trial Rules - Sponsors Interested But 'FAQ' Could Help

16 Apr 2019

India Cuts Prices Of 463 Anticancers But Loose Ends Remain

12 Mar 2019

AstraZeneca's Calquence Steps Into Blood Cancer Ring With Mighty Imbruvica

01 Nov 2017

Related Companies

AstraZeneca PLC

Pfizer Inc.

Eli Lilly and Company

Pfizer Inc.

Additional Topics

India Asia Pacific Policy Review Pathway Clinical Trials BioPharmaceutical

More from India

More from Asia

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.